Bruker Corp
NASDAQ:BRKR

Watchlist Manager
Bruker Corp Logo
Bruker Corp
NASDAQ:BRKR
Watchlist
Price: 57.07 USD 1.51% Market Closed
Market Cap: 8.7B USD
Have any thoughts about
Bruker Corp?
Write Note

Bruker Corp
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bruker Corp
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Bruker Corp
NASDAQ:BRKR
Other Long-Term Assets
$579m
CAGR 3-Years
41%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Other Long-Term Assets
$4.2B
CAGR 3-Years
12%
CAGR 5-Years
28%
CAGR 10-Years
18%
Danaher Corp
NYSE:DHR
Other Long-Term Assets
$2.5B
CAGR 3-Years
0%
CAGR 5-Years
26%
CAGR 10-Years
8%
Mettler-Toledo International Inc
NYSE:MTD
Other Long-Term Assets
$396.2m
CAGR 3-Years
17%
CAGR 5-Years
27%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Other Long-Term Assets
$573m
CAGR 3-Years
1%
CAGR 5-Years
-1%
CAGR 10-Years
2%
IQVIA Holdings Inc
NYSE:IQV
Other Long-Term Assets
$631m
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
15%
No Stocks Found

Bruker Corp
Glance View

Market Cap
8.7B USD
Industry
Life Sciences Tools & Services

Bruker Corporation stands as a pivotal player in the life sciences and analytical instrument markets, renowned for its innovative technologies that empower researchers and laboratories worldwide. Founded in 1960, Bruker has consistently focused on developing advanced scientific instruments that enhance the understanding of biological processes and materials. Through its diverse portfolio, which includes high-performance mass spectrometry, nuclear magnetic resonance (NMR), and microscopy systems, Bruker addresses critical challenges in fields such as drug discovery, environmental analysis, and clinical diagnostics. With a commitment to innovation, the company is well-positioned to benefit from ongoing trends in healthcare and life sciences, promising an exciting growth trajectory for potential investors. As the global scientific community increasingly turns to precise analytics and advanced diagnostics, Bruker’s offerings align perfectly with the burgeoning demand for cutting-edge research tools. The company has cultivated strong relationships with academic institutions, government agencies, and pharmaceutical companies, ensuring a robust customer base. Furthermore, with a focus on sustainability and reducing environmental impact, Bruker is tapping into new market segments that prioritize eco-friendly solutions. With a solid financial foundation, a history of strategic acquisitions, and ongoing investments in research and development, Bruker Corporation represents a compelling opportunity for investors looking to gain exposure to the dynamic fields of life sciences and analytical technology.

BRKR Intrinsic Value
70.32 USD
Undervaluation 19%
Intrinsic Value
Price

See Also

What is Bruker Corp's Other Long-Term Assets?
Other Long-Term Assets
579m USD

Based on the financial report for Sep 30, 2024, Bruker Corp's Other Long-Term Assets amounts to 579m USD.

What is Bruker Corp's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 3Y
41%

Over the last year, the Other Long-Term Assets growth was 41%. The average annual Other Long-Term Assets growth rates for Bruker Corp have been 41% over the past three years .

Back to Top